- Home
- MRNA vs CHWY Comparison
MRNA vs CHWY Comparison
Compare MRNA & CHWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- CHWY
- Stock Information
- Founded
- MRNA 2010
- CHWY 2010
- Country
- MRNA United States
- CHWY United States
- Employees
- MRNA N/A
- CHWY N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- CHWY Catalog/Specialty Distribution
- Sector
- MRNA Health Care
- CHWY Consumer Discretionary
- Exchange
- MRNA Nasdaq
- CHWY Nasdaq
- Market Cap
- MRNA 10.6B
- CHWY 13.4B
- IPO Year
- MRNA 2018
- CHWY 2019
- Fundamental
- Price
- MRNA $24.68
- CHWY $39.05
- Analyst Decision
- MRNA Hold
- CHWY Buy
- Analyst Count
- MRNA 20
- CHWY 23
- Target Price
- MRNA $51.94
- CHWY $38.56
- AVG Volume (30 Days)
- MRNA 8.6M
- CHWY 5.7M
- Earning Date
- MRNA 05-01-2025
- CHWY 05-28-2025
- Dividend Yield
- MRNA N/A
- CHWY N/A
- EPS Growth
- MRNA N/A
- CHWY 911.11
- EPS
- MRNA N/A
- CHWY 0.91
- Revenue
- MRNA $3,177,000,000.00
- CHWY $11,861,335,000.00
- Revenue This Year
- MRNA N/A
- CHWY $7.87
- Revenue Next Year
- MRNA $22.14
- CHWY $6.92
- P/E Ratio
- MRNA N/A
- CHWY $42.02
- Revenue Growth
- MRNA N/A
- CHWY 6.40
- 52 Week Low
- MRNA $23.15
- CHWY $14.85
- 52 Week High
- MRNA $170.47
- CHWY $40.09
- Technical
- Relative Strength Index (RSI)
- MRNA 42.25
- CHWY 67.83
- Support Level
- MRNA $23.70
- CHWY $36.01
- Resistance Level
- MRNA $28.52
- CHWY $37.61
- Average True Range (ATR)
- MRNA 1.34
- CHWY 1.27
- MACD
- MRNA -0.03
- CHWY 0.26
- Stochastic Oscillator
- MRNA 29.80
- CHWY 96.37
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About CHWY Chewy Inc.
Chewy is the largest e-commerce pet care retailer in the US, generating $11.2 billion in 2023 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a stand-alone company in 2019 after spending a couple of years developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods, like crates, leashes, and bowls.